immunoteraapiaga

Immunoteraapia is a type of cancer treatment that uses the body's own immune system to fight cancer. The immune system is a complex network of cells, tissues, and organs that defend the body against infections and diseases. Cancer cells can sometimes evade the immune system, allowing them to grow and spread. Immunoteraapia works by helping the immune system recognize and attack cancer cells more effectively.

There are several different types of immunoteraapia. One common type is checkpoint inhibitors. These drugs block proteins that act as "brakes" on the immune system, allowing immune cells to attack cancer more aggressively. Another type is CAR T-cell therapy, where a patient's own immune cells (T-cells) are genetically modified in a lab to recognize and kill cancer cells, and then infused back into the patient. Other forms include cancer vaccines, which stimulate an immune response against cancer cells, and monoclonal antibodies, which can target specific proteins on cancer cells or flag them for destruction by the immune system.

Immunoteraapia has shown significant promise in treating various types of cancer, including melanoma, lung cancer, and certain blood cancers. However, like all medical treatments, it can also have side effects. These can range from mild, flu-like symptoms to more serious immune-related reactions where the immune system mistakenly attacks healthy tissues. The effectiveness and side effects of immunoteraapia can vary greatly depending on the type of cancer, the specific drug used, and the individual patient. Research continues to explore new ways to enhance its efficacy and manage its side effects.